Welcome to our dedicated page for Lionsgate studios SEC filings (Ticker: LION), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lionsgate Studios’ box-office hits and binge-worthy series generate complex revenue streams—from theatrical windows to global streaming licenses—that show up in hundreds of pages of SEC disclosures. If you’ve ever searched for where film library valuation lives inside a Lionsgate Studios annual report 10-K simplified or wondered how production costs flow through a quarterly earnings report 10-Q filing, this page was built for you.
Stock Titan’s AI models distill every document the moment it hits EDGAR, so understanding Lionsgate Studios SEC documents with AI is as easy as opening a summary card. Need real-time alerts? We flag Lionsgate Studios Form 4 insider transactions real-time, letting you monitor executive stock transactions Form 4 before and after major release dates.
Here’s what you’ll find: the latest Lionsgate Studios insider trading Form 4 transactions, each parsed for share price, option grants, and timing; concise breakouts of Lionsgate Studios quarterly earnings report 10-Q filing cash-flow swings tied to marketing spend; and a film-library impairment tracker pulled straight from the Lionsgate Studios annual report 10-K simplified. We also tag every Lionsgate Studios proxy statement executive compensation table, so you can see how profit-participation bonuses align with franchise performance, and we translate every Lionsgate Studios 8-K material events explained into plain language.
Whether you’re comparing segment revenue trends, tracking share repurchases, or scanning Lionsgate Studios earnings report filing analysis for upcoming slate clues, our comprehensive coverage and AI-powered summaries mean less time searching and more time deciding.
Form 4 filing overview (Lionsgate Studios Corp., ticker LION). General Counsel Bruce Tobey reported three equity transactions on 03 July 2025 connected with the vesting of previously granted restricted share units (RSUs) and related tax withholding.
- Share withholding for taxes (Code F): 9,999 common shares at an implied price of $5.80 and 7,499 shares at $5.85 were automatically surrendered to cover statutory tax obligations.
- Share issuance on vesting (Code A): 14,768 common shares were issued at $0 cost when 75 % of a performance-based RSU award vested.
- Resulting ownership: Tobey’s direct beneficial stake changed from approximately 304,391 shares before the first withholding to 301,661 shares after all entries—a net reduction of 2,730 shares (-0.9 %).
- Unvested equity still outstanding: Footnote 2 details 230,508 RSUs scheduled to vest between 2026 – 2028 under the 2025 Performance Incentive Plan.
Transactions were non-open-market and routine in nature, reflecting compensation-related share delivery and tax settlement rather than discretionary buying or selling. No derivative securities were reported. The filing does not indicate any strategic change in insider sentiment or corporate outlook.